Disease Markers / 2022 / Article / Tab 2 / Research Article
Prognostic Markers in Hospitalized COVID-19 Patients: The Role of IP-10 and C-Reactive Protein Table 2 Baseline routine laboratory findings and multiplex quantifications in patients with an adverse disease evolution (death/ICU admitted) vs. all the other patients. Data are expressed as medians (IQR). Bold text highlights the statistically significant results.
Laboratory findings at baseline ( ) Adverse disease evolution ( ) All other patients ( ) valueHemoglobin (g/dL) 14.3 [11.9-15.1] 14.2 [12.9-15.0] 0.3708 0.7108 RDW-CV (%) 13.6 [13.0-14.4] 13.3 [12.8-13.8] 2.0285 0.0425 White blood cells ( ) 8.12 [5.12-9.87] 6.99 [5.05-9.21] 0.2385 0.8115 Neutrophils ( ) 5.70 [4.20-9.15] 5.67 [4.20-7.93] 0.3940 0.6936 Eosinophils ( ) 0.00 [0.00-0.00] 0.00 [0.00-0.00] 0.2413 0.8093 Lymphocytes ( ) 0.62 [0.39-0.77] 0.74 [5.70-0.99] -2.2837 0.0224 Neutrophil/lymphocyte ratio 11.90 [4.97-17.60] 7.88 [4.70-10.55] 1.7909 0.0733 Platelets ( ) 162 [128-200] 219 [176-273] -4.1859 0.0001 ALT (U/L) 36 [27-57] 37 [28-55] -0.1949 0.8455 AST (U/L) 43 [36-70] 41 [31-56] 1.2971 0.1946 Bilirubin (mg/dL) 0.7 [0.5-0.8] 0.6 [0.5-0.8] 1.1019 0.2705 Creatinine (mg/dL) 0.91 [0.77-1.24] 0.78 [0.64-0.90] 2.6236 0.0087 Glomerular filtration rate (mL/min) 75 [61-90] 93 [74-103] -2.8489 0.0044 CRP (mg/dL) 10.2 [5.6-15.5] 7.7 [4.1-12.0] 1.8531 0.0639 LDH (U/L) 784 [694-1010] 690 [535-864] 2.1414 0.0322 Erythrocyte sedimentation rate (mm/h) 44 [25-56] 40 [31-50] 0.6988 0.4847 Troponin I (ng/mL) 13 [4-17] 7 [2-14] 1.7752 0.0759 Ferritin (ng/mL) 1155 [608-1921] 793 [371-1245] 2.2487 0.0245 D-dimer (μ g/L) 1175 [593-1773] 667 [481-1056] 2.2821 0.0225 Albumin (g/dL) 4.0 [3.7-4.3] 4.0 [3.7-4.2] 0.6087 0.5427 Eotaxin (pg/mL) 3.45 [2.97-4.13] 3.68 [2.62-4.78] -0.0467 0.9628 FGF (pg/mL) 12.68 [0.00-17.49] 15.72 [5.03-22.55] -1.6272 0.1037 G-CSF (pg/mL) 61.47 [43.47-111.57] 64.27 [43.47-91.38] -0.6610 0.5086 GM-CSF (pg/mL) 0.00 [0.00-0.00] 0.00 [0.00-0.00] 1.8897 0.0588 IFN-γ (pg/mL) 7.64 [5.56-9.70] 7.37 [5.20-9.98] 0.1919 0.8478 IL-1β (pg/mL) 0.16 [0.00-1.03] 0.53 [0.00-1.43] -0.5697 0.5689 IL1-RA (pg/mL) 0.00 [0.00-168.65] 0.00 [0.00-168.65] -0.2656 0.7906 IL-2 (pg/mL) 0.07 [0.00-1.79] 1.50 [0.00-4.34] -1.8431 0.0653 IL-4 (pg/mL) 0.58 [0.00-0.90] 0.32 [0.00-0.73] 1.1959 0.2317 IL-5 (pg/mL) 0.00 [0.00-48.48] 0.00 [0.00-107.56] -1.4608 0.1441 IL-6 (pg/mL) 20.12 [11.51-42.41] 8.17 [3.8-22.45] 2.7546 0.0059 IL-7 (pg/mL) 7.44 [1.93-19.94] 8.57 [1.93-22.56] -0.7296 0.4656 IL-8 (pg/mL) 22.60 [16.77-44.72] 15.95 [11.18-25.20] 2.7034 0.0069 IL-9 (pg/mL) 456.18 [401.78-493.75] 456.86 [403.68-553.68] -1.0004 0.3171 IL-10 (pg/mL) 2.05 [0.13-3.11] 1.27 [0.00-4.42] 0.4075 0.6837 IL-12 (pg/mL) 0.95 [0.00-3.23] 2.21 [0.00-4.68] -1.8208 0.0686 IL-13 (pg/mL) 0.00 [0.00-0.49] 0.00 [0.00-0.79] -0.1276 0.8985 IL-15 (pg/mL) 0.00 [0.00-84.08] 0.00 [0.00-273.20] -1.0831 0.2788 IL-17 (pg/mL) 4.37 [3.65-5.95] 4.37 [2.91-6.33] 0.5474 0.5841 IP-10 (pg/mL) 7520.77 [4953.57-12322.33] 3451.44 [2102.05-5850.57] 4.8026 0.0001 MCP-1 (pg/mL) 121.31 [67.56-203.32] 75.11 [40.74-103.27] 2.6877 0.0072 MIP-1α (pg/mL) 1.89 [1.29-2.95] 1.69 [1.04-2.66] 0.6768 0.4985 MIP-1β (pg/mL) 222.66 [198.75-241.60] 228.00 [194.67-257.58] -0.8683 0.3853 PDGF (pg/mL) 1040.46 [614.45-1910.19] 1370.46 [723.44-2622.26] -1.4074 0.1593 RANTES (pg/mL) 5525.30 [2952.02-8016.74] 5300.72 [2982.24-10540.92] -0.9823 0.3260 TNF-α (pg/mL) 19.12 [15.42-20.63] 21.91 [16.17-27.47] -1.9106 0.0561 VEGF (pg/mL) 178.91 [19.79-230.35] 198.68 [48.82-291.68] -1.1787 0.2385